4th Quarter - Report

EMPIRE CONSULTING GROUP for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues pertaining to cell and gene therapies; the National Defense Authorization Act; Omnibus legislation; and to Vertex's scientific advances/innovations and therapies.

LobbyistCovered position, as disclosed
MIKE MCKAY —

Contacted: White House Office; Defense, Dept of (DOD); SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Treasury, Dept of

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.